Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Prevention or treatment of hematologic malignancy relapse using a TNFR2 antagonist

US Patent 11359027 · Granted Jun 14, 2022

Assignee

Inventors

View full patent text on Google Patents →